Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma
暂无分享,去创建一个
[1] Yan Sun,et al. Reduced expression of vasohibin-1 is associated with clinicopathological features in renal cell carcinoma , 2012, Medical Oncology.
[2] Y. Okada,et al. The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma , 2012, Clinical Cancer Research.
[3] Yasufumi Sato. The vasohibin family: Novel regulators of angiogenesis. , 2012, Vascular pharmacology.
[4] T. Fujioka,et al. Brain-specific angiogenesis inhibitor 1 is a putative factor for inhibition of neovascular formation in renal cell carcinoma. , 2011, The Journal of urology.
[5] H. Sasano,et al. Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas , 2011, Cancer science.
[6] H. Sasano,et al. Vasohibin‐1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast , 2010, Cancer science.
[7] Gyan Bhanot,et al. Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns. , 2010, Genes & cancer.
[8] T. Shinka,et al. Angiogenesis in renal cell carcinoma: The role of tumor‐associated macrophages , 2009, International journal of urology : official journal of the Japanese Urological Association.
[9] O. Tawfik,et al. Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma. , 2009, Archives of pathology & laboratory medicine.
[10] T. Shimosegawa,et al. Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. , 2009, Blood.
[11] H. Sasano,et al. Vasohibin‐1 in human breast carcinoma: A potential negative feedback regulator of angiogenesis , 2009, Cancer science.
[12] N. Yaegashi,et al. Expression of vasohibin as a novel endothelium‐derived angiogenesis inhibitor in endometrial cancer , 2008, Cancer science.
[13] R. Montironi,et al. Prognostic Role of Tumor Necrosis, Microvessel Density, Vascular Endothelial Growth Factor and Hypoxia Inducible Factor-1α in Patients with Clear Cell Renal Carcinoma after Radical Nephrectomy in a Long Term Follow-up , 2008, International journal of immunopathology and pharmacology.
[14] F. Goze,et al. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma , 2008, BJU international.
[15] Francesca Demichelis,et al. Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. , 2007, Human pathology.
[16] K. Grankvist,et al. Evaluation of CD31 (PECAM-1) Expression Using Tissue Microarray in Patients with Renal Cell Carcinoma , 2007, Tumor Biology.
[17] R. Montironi,et al. Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens. , 2005, The Journal of urology.
[18] T. Oda,et al. Expression and localization of mRNAs for matrix metalloproteinases and their inhibitors in mixed bronchioloalveolar carcinomas with invasive components , 2005, Modern Pathology.
[19] T. Shuin,et al. Levels of angiogenesis and expression of angiogenesis‐related genes are prognostic for organ‐specific metastasis of renal cell carcinoma , 2005, Cancer.
[20] Manuel Hidalgo,et al. Matrix metalloproteinase-2 contributes to cancer cell migration on collagen. , 2005, Cancer research.
[21] M. Egawa,et al. Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma , 2004, International journal of urology : official journal of the Japanese Urological Association.
[22] M. Abe,et al. Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. , 2004, The Journal of clinical investigation.
[23] Sun-Ja Kim,et al. Increased expression of caveolin‐1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma , 2004, BJU international.
[24] T. Ochiya,et al. Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. , 2003, Biochemical and biophysical research communications.
[25] S. Baltacı,et al. Thrombospondin-1, vascular endothelial growth factor expression and microvessel density in renal cell carcinoma and their relationship with multifocality. , 2003, European urology.
[26] M. Marberger,et al. Expression of platelet-derived growth factor-alpha alpha receptor is associated with tumor progression in clear cell renal cell carcinoma. , 2003, American journal of clinical pathology.
[27] M. Nishikido,et al. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[28] Holger Moch,et al. VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma , 2002, The Journal of pathology.
[29] S. J. Lee,et al. Clinical significance of urinary vascular endothelial growth factor and microvessel density in patients with renal cell carcinoma. , 2001, Urology.
[30] H. Radzun,et al. Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas , 2001, Virchows Archiv.
[31] N. Rioux-Leclercq,et al. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma. , 2001, Human pathology.
[32] N. Kawata,et al. Histopathologic analysis of angiogenic factors in localized renal cell carcinoma: The influence of neoadjuvant treatment , 2001, International journal of urology : official journal of the Japanese Urological Association.
[33] W. Kaelin,et al. The von Hippel-Lindau tumor suppressor gene. , 2001, Experimental cell research.
[34] E. Sabo,et al. Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] T. Morita,et al. Thymidine phosphorylase/platelet-derived endothelial cell growth factor (PD-ECGF) associated with prognosis in renal cell carcinoma , 2001, Urological Research.
[36] A. El‐Naggar,et al. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. , 2001, The American journal of pathology.
[37] D. Nicol,et al. Vascular endothelial growth factor expression is increased in renal cell carcinoma. , 1997, The Journal of urology.
[38] M. Volm,et al. Microvessel density and vascular endothelial growth factor expression in human tumors of different localization. , 1996, Oncology reports.
[39] D. Bostwick,et al. Microvessel density in renal cell carcinoma: lack of prognostic significance. , 1995, Urology.
[40] K. Okada,et al. PROGNOSTIC SIGNIFICANCE OF MICROVESSEL COUNT IN LOW STAGE RENAL CELL CARCINOMA , 1995, International journal of urology : official journal of the Japanese Urological Association.
[41] T. Sugimura,et al. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. , 1994, Cancer research.
[42] E. Manseau,et al. Vascular permeability factor mRNA and protein expression in human kidney. , 1992, Kidney international.
[43] E. Lang. Arteriographic assessment and staging of renal-cell carcinoma. Analysis of a series of 120 patients. , 1971, Radiology.
[44] G. Netto,et al. The relationship of vascular endothelial growth factor and coagulation factor (fibrin and fibrinogen) expression in clear cell renal cell carcinoma. , 2010, Urology.
[45] Yasufumi Sato,et al. The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells. , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[46] Ricky T. Tong,et al. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model. , 2005, Cancer research.
[47] M. Marberger,et al. Expression of platelet-derived growth factor-alpha alpha receptor is associated with tumor progression in clear cell renal cell carcinoma. , 2003, American journal of clinical pathology.
[48] E. Lang. Arteriographic assessment and staging of renal cell carcinoma. , 1976, Panminerva medica.